TAIMED BIOLOGICS INC.

 

Area: Pharmaceutical and Medical Devices

Booth No: R305

Website: http://www.taimedbiologics.com/

 

Exhibitor Profile

 

TaiMed Biologics was formed in 2007 to realize the vision of creating a world-class, innovation-based biotechnology company that will satisfy unmet medical needs. We have vast experience in mAb development and manufacturing and successfully launched the first and only mAb for HIV treatment in US and EU (Trogarzo®).
With our massive expertise, we provide CDMO services including GMP manufacturing, process/ analytical method development, and validation to propel client's commercialization process.

 

Brands

 

TaiMed Biologics Inc., Trogarzo, CMO/CDMO

 

Video

 

• 

  CDMO Services

• 

  Taimed Biologics Introduction

• 

  Trogarzo (Ibalizumab) TMB-355 mechanism

 

 

Exhibit Products

 

• 

  Regulatory Affairs

• 

  cGMP Manufacturing

• 

  Formulation Development

• 

  Analysis and Analytical Method Development

• 

  Process Development

• 

  TMB-365/TMB-380 (TMB-365 and TMB-380 combination)

• 

  TMB-380 (VRC07-523LS)

• 

  TMB-365

 

Exhibitor Press Release

 

• TaiMed is your reliable biologics CDMO partner 2022-07-27
• Join TaiMed Biologics for company presentation on July 28th, 11:15-11:30 am (Room 702) 2022-07-18
• TaiMed can be your Trusted CDMO for mAB development 2022-07-18
• Tanvex BioPharma and TaiMed Biologics form a business alliance to offer efficient CDMO services 2022-06-14
• TAIMED JOINS THE 2022 BIO INTERNATIONAL CONVENTION IN SAN DIEGO AND 2022 BIO ASIA TAIWAN IN TAIPEI 2022-06-14

 

Floor Plan

 

 

 

 

back